[1]
“Role of Pyridine and Pyrimidine-Based Kinase Inhibitors in Cancer Treatment: Selectivity, Resistance, and Next-Generation Designs”, AJBR, vol. 27, no. 4S, pp. 18493–18529, Nov. 2022, doi: 10.53555/AJBR.v27i4s.8728.